Transformation of the antibacterial agent norfloxacin by environmental mycobacteria

Applied and Environmental Microbiology

Volumn 72, Issue 9, 2006, Pages 5790-5793

  Adjei, Michael D ^a,b   Heinze, Thomas M ^a   Deck, Joanna ^a   Freeman, James P ^a   Williams, Anna J ^a   Sutherland, John B ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Norfolk Department of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DRUG PRODUCTS; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; YEAST;

AGAR DILUTION METHOD; FLUOROQUINOLONES; MYCOBACTERIUM STRAINS; NORFLOXACIN;

BACTERIOLOGY;

ACETIC ACID ETHYL ESTER; ANTIBIOTIC AGENT; DRUG METABOLITE; N ACETYLNORFLOXACIN; N NITROSNORFLOXACIN; NITROSAMINE; NORFLOXACIN; SORBITOL; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOTRANSFORMATION; DRUG; METABOLITE; YEAST;

AGAR DILUTION METHOD; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOTRANSFORMATION; CARCINOGENICITY; CULTURE MEDIUM; DILUTION; DRUG TRANSFORMATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM GILVUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; YEAST;

ANTI-BACTERIAL AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL MICROBIOLOGY; ENVIRONMENTAL POLLUTANTS; MAGNETIC RESONANCE SPECTROSCOPY; MYCOBACTERIUM; NORFLOXACIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM GILVUM; MYCOBACTERIUM SP.;

EID: 33748799954     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.03032-05     Document Type: Article

References (41)

1. Alexander, M. 1999. Biodegradation and bioremediation, 2nd ed. Academic Press, San Diego, Calif.
2. Bhaumik, A. 1997. Effect of norftoxacin treatment in acute enteritis in dogs. Ind. Vet. J. 74:246-247.
3. Blau, K. 1993. Acylation, p. 31-50. In K. Blau and J. M. Halket (ed.), Handbook of derivatives for chromatography, 2nd ed. John Wiley & Sons, Chichester, United Kingdom.
4. Blevins, W. T., and J. J. Perry. 1972. Metabolism of propane, n-propylamine, and propionate by hydrocarbon-utilizing bacteria. J. Bacteriol. 112:513-518.
5. Boldrin, B., A. Tiehm, and C. Fritzsche. 1993. Degradation of phenanthrene, fluorene, fluoranthene, and pyrene by a Mycobacterium sp. Appl. Environ. Microbiol. 59:1927-1930.
6. Calmels, S., H. Ohshima, and H. Bartsch. 1988. Nitrosamine formation by denitrifying and non-denitrifying bacteria: implication of nitrite reductase and nitrate reductase in nitrosation catalysis. J. Gen. Microbiol. 134:221-226.
7. 1-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines. Carcinogenesis 17:533-536.
8. Chen, Y., J. P. N. Rosazza, C. P. Reese, H.-Y. Chang, M. A. Nowakowski, and J. P. Kiplinger. 1997. Microbial models of soil metabolism: biotransformations of danofloxacin. J. Ind. Microbiol. Biotechnol. 19:378-384.
9. Dean-Ross, D., and C. E. Cerniglia. 1996. Degradation of pyrene by Mycobacterium flavescens. Appl. Microbiol. Biotechnol. 46:307-312.
10. Domurado, D., A.-M. Balazuc, M. Lagranderie, P. Pescher, P. Chavarot, E. Roseeuw, V. Coessens, S. Stern, E. Schacht, and G. Marchal. 2005. Targeted norfloxacin is active in vivo against persistent Mycobacterium bovis BCG. J. Controlled Release 101:343-345.
11. Golet, E. M., A. C. Alder, A. Hartmann, T. A. Ternes, and W. Giger. 2001. Trace determination of fluoroquinolone antibacterial agents in urban waste-water by solid-phase extraction and liquid chromatography with fluorescence detection. Anal. Chem. 73:3632-3638.
12. Hayes, J. R., L. L. English, L. E. Carr, D. D. Wagner, and S. W. Joseph. 2004. Multiple-antibiotic resistance of Enterococcus spp. isolated from commercial poultry production environments. Appl. Environ. Microbiol. 70:6005-6011.
13. Heitkamp, M. A., W. Franklin, and C. E. Cerniglia. 1988. Microbial metabolism of polycyclic aromatic hydrocarbons: isolation and characterization of a pyrene-degrading bacterium. Appl. Environ. Microbiol. 54:2549-2555.
14. Jorgensen, J. H., J. D. Turnidge, and J. A. Washington. 1999. Antibacterial susceptibility tests: dilution and disk diffusion methods, p. 1526-1543. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
15. Kim, Y.-H., K.-H. Engesser, and C. E. Cerniglia. 2003. Two polycyclic aromatic hydrocarbon o-quinone reductases from a pyrene-degrading Mycobacterium. Arch. Biochem. Biophys. 416:209-217.
16. Kim, Y.-H., K.-H. Engesser, and C. E. Cerniglia. 2005. Numerical and genetic analysis of polycyclic aromatic hydrocarbon-degrading mycobacteria. Microb. Ecol. 50:110-119.
17. Lawrenson, R. A., and J. W. Logie. 2001. Antibiotic failure in the treatment of urinary tract infections in young women. J. Antimicrob. Chemother. 48:895-901.
18. Li, X.-Z., L. Zhang, and H. Nikaido. 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:2415-2423.
19. Lijinsky, W. 1999. N-Nitroso compounds in the diet. Mutat. Res. 443:129-138.
20. Love, L. A., W. Lijinsky, L. K. Keefer, and H. Garcia. 1977. Chronic oral administration of 1-nitrosopiperazine at high doses to MRC rats. Z. Krebsforsch. Klin. Onkol. 89:69-73.
21. Lundberg, J. O., E. Weitzberg, J. A. Cole, and N. Benjamin. 2004. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2:593-602.
22. Morley, J. A., and L. Elrod. 1993. Determination of fluoroquinolone antibacterials as N-acyl derivatives. Chromatographia 37:295-299.
23. Parshikov, I. A., J. P. Freeman, J. O. Lay, R. D. Beger, A. J. Williams, and J. B. Sutherland. 1999. Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol. Lett. 177:131-135.
24. Parshikov, I. A., J. P. Freeman, J. O. Lay, J. D. Moody, A. J. Williams, R. D. Beger, and J. B. Sutherland. 2001. Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus. J. Ind. Microbiol. Biotechnol. 26:140-144.
25. Parshikov, I. A., T. M. Heinze, J. D. Moody, J. P. Freeman, A. J. Williams, and J. B. Sutherland. 2001. The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norftoxacin. Appl. Microbiol. Biotechnol. 56:474-477.
26. Pauliukonis, L. T., D. G. Musson, and W. F. Bayne. 1984. Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reverse-phase chromatography. J. Pharm. Sci. 73:99-102.
27. Payton, M., R. Auty, R. Delgoda, M. Everett, and E. Sim. 1999. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J. Bacteriol. 181:1343-1347.
28. Pierini, E., G. Famiglini, F. Mangani, and A. Cappiello. 2004. Fate of enrofloxacin in swine sewage. J. Agric. Food Chem. 52:3473-3477.
29. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.
30. Saini, S. P. S., and A. K. Srivastava. 2001. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis). Vet. Res. Commun. 25:641-649.
31. Schneider, J., R. Grosser, K. Jayasimhulu, W. Xue, and D. Warshawsky. 1996. Degradation of pyrene, benz[a]anthracene, and benzo[a]pyrene by Mycobacterium sp. strain RJGII-135, isolated from a former coal gasification site. Appl. Environ. Microbiol. 62:13-19.
32. Sidgwick, N. V. 1966. The organic chemistry of nitrogen, 3rd ed., revised by I. T. Millar and H. D. Springall. Clarendon Press, Oxford, United Kingdom.
33. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
34. Sumano, L. H., C. L. Ocampo, G. W. Brumbaugh, and R. E. Lizarraga. 1998. Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers. Br. Poult. Sci. 39:42-46.
35. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W.-M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
36. Texier-Maugein, J., M. Mormède, J. Fourche, and C. Bébéar. 1987. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria. Eur. J. Clin. Microbiol. 6:584-586.
37. Wetzstein, H.-G., N. Schmeer, and W. Karl. 1997. Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites. Appl. Environ. Microbiol. 63:4272-4281.
38. Williams, K. J., G. A. C. Chung, and L. J. V. Piddock. 1998. Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis. Antimicrob. Agents Chemother. 42:795-800.
39. Willumsen, P., U. Karlson, E. Stackebrandt, and R. M. Kroppenstedt. 2001. Mycobacterium frederiksbergense sp. nov., a novel polycyclic aromatic hydrocarbon-degrading Mycobacterium species. Int. J. Syst. Evol. Microbiol. 51:1715-1722.
40. Wright, G. D. 2005. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv. Drug Deliv. Rev. 57:1451-1470.
41. Ziebarth, D., B. Spiegelhalder, and H. Bartsch. 1997. N-Nitrosation of medicinal drugs catalyzed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Carcinogenesis 18:383-389.